Acciones Sirona Biochem Corp. Other OTC
Acciones
SRBCF
CA82967M1005
Biotecnología e investigación médica
Ventas 2022 | 672 mil 492 mil 453 mil | Ventas 2023 | 34,78 mil 25,49 mil 23,47 mil | Capitalización | 21,44 M 15,71 M 14,47 M |
---|---|---|---|---|---|
Resultado Neto 2022 | -3 M -2,2 M -2,02 M | Resultado Neto 2023 | -2 M -1,47 M -1,35 M | VE / Ventas 2022 | 48,8 x |
Deuda neta 2022 | 48,04 mil 35,2 mil 32,42 mil | Deuda neta 2023 | 1,61 M 1,18 M 1,09 M | VE / Ventas 2023 | 663 x |
P/E ratio 2022 |
-8,81
x | P/E ratio 2023 |
-8,43
x | Empleados | - |
Rendimiento 2022 * |
-
| Rendimiento 2023 |
-
| Flotante | 89,41 % |
Directores | Puesto | Edad | Desde |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19/10/06 |
Director of Finance/CFO | - | 29/04/09 | |
Chief Tech/Sci/R&D Officer | - | 31/03/11 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Howard Verrico
CEO | Chief Executive Officer | - | 19/10/06 |
Alex Marazzi
BRD | Director/Board Member | - | 19/10/06 |
Director of Finance/CFO | - | 29/04/09 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+54,05 % | 63,85 mil M | |
-2,02 % | 41,83 mil M | |
+40,01 % | 40,47 mil M | |
-10,22 % | 27,17 mil M | |
+13,42 % | 26,52 mil M | |
-21,60 % | 18,69 mil M | |
+2,89 % | 12,73 mil M | |
+22,40 % | 12,11 mil M | |
+27,49 % | 12,07 mil M |